# Point in Time of Radiotherapy for Patients With Biochemical Recurrent Prostate Carcinoma

> **NCT02181192** · NA · UNKNOWN · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 180 (estimated)

## Conditions studied

- Prostate Cancer
- Recurrence

## Interventions

- **DEVICE:** PET/CT
- **RADIATION:** Instant Radiotherapy according to guidelines
- **RADIATION:** Radiotherapy after achievement of PSA marginal value

## Key facts

- **NCT ID:** NCT02181192
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07
- **Primary completion:** 2019-07
- **Final completion:** 2020-07
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2016-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02181192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02181192, "Point in Time of Radiotherapy for Patients With Biochemical Recurrent Prostate Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02181192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*